Skip to content
Lucid News· Jack Gorsline·AI score42

VA launches five-site PIVOT trial of COMP360 psilocybin for veterans with treatment-resistant depression

Psychedelic Policy Briefing 8.14.26

AI summary

The U.S. Department of Veterans Affairs launched PIVOT on August 5, a five-site trial of Compass Pathways' COMP360 psilocybin in veterans with treatment-resistant depressionDepression that has not improved enough after adequate courses of at least two antidepressant treatments.Open the glossary.

Key facts

Compound
Psilocybin
Condition
Depression
Organisation
Compass Pathways
Jurisdiction
United States
Source
Lucid News (lucid.news)
Published
How this summary was made

The summary was written by an AI model from the linked source, and a model scored the item against this site's editorial criteria. The facts above come from the item's topics and from identifiers written out in the stored text. Anything not found there is left out, so a missing row means not stated, not no. Read the original before relying on any detail. Editorial method

Source: Lucid News · lucid.news

Connected to

Compound
Psilocybin
Condition
Depression
Organisation
Compass Pathways
Jurisdiction
United States

Other recent items on these topics